Designing antisense oligonucleotides aspharmaceutical agents
- 1 November 1989
- journal article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 10 (11), 435-437
- https://doi.org/10.1016/s0165-6147(89)80004-5
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Effect of Phosphorothioate Homo-oligodeoxy nucleotides on Herpes Simplex Virus Type 2-induced DNA PolymerasePublished by Elsevier ,1989
- Stereochemical Course of Catalysis by the Tetrahymena RibozymeScience, 1989
- Stereochemistry of RNA Cleavage by the Tetrahymena Ribozyme and Evidence that the Chemical Step Is Not Rate-LimitingScience, 1989
- Phosphorothioates in molecular biologyTrends in Biochemical Sciences, 1989
- Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotidesNucleic Acids Research, 1989
- Antisense RNA: its functions and applications in gene regulation — a reviewGene, 1988
- Simple RNA enzymes with new and highly specific endoribonuclease activitiesNature, 1988
- Site-Specific Oligonucleotide Binding Represses Transcription of the Human c- myc Gene in VitroScience, 1988
- Antisense DNA and RNA: progress and prospects.Genes & Development, 1988
- Sequence-Specific Cleavage of Double Helical DNA by Triple Helix FormationScience, 1987